UBS Group AG lifted its holdings in Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) by 1.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 66,937 shares of the biotechnology company’s stock after buying an additional 939 shares during the period. UBS Group AG owned approximately 0.09% of Axon Enterprise worth $7,748,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Arizona State Retirement System raised its stake in Axon Enterprise by 0.4% during the third quarter. Arizona State Retirement System now owns 18,332 shares of the biotechnology company’s stock worth $2,122,000 after purchasing an additional 71 shares during the period. IFP Advisors Inc raised its stake in Axon Enterprise by 36.8% during the third quarter. IFP Advisors Inc now owns 364 shares of the biotechnology company’s stock worth $28,000 after purchasing an additional 98 shares during the period. Atria Wealth Solutions Inc. raised its stake in Axon Enterprise by 5.7% during the second quarter. Atria Wealth Solutions Inc. now owns 2,168 shares of the biotechnology company’s stock worth $202,000 after purchasing an additional 116 shares during the period. Signaturefd LLC raised its stake in Axon Enterprise by 27.8% during the third quarter. Signaturefd LLC now owns 598 shares of the biotechnology company’s stock worth $69,000 after purchasing an additional 130 shares during the period. Finally, Raymond James Trust N.A. raised its stake in Axon Enterprise by 3.3% during the third quarter. Raymond James Trust N.A. now owns 4,403 shares of the biotechnology company’s stock worth $510,000 after purchasing an additional 142 shares during the period. 75.62% of the stock is owned by hedge funds and other institutional investors.
Axon Enterprise Trading Down 0.8 %
Shares of AXON stock opened at $193.55 on Friday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.39 and a current ratio of 2.79. The stock has a market capitalization of $13.77 billion, a P/E ratio of 133.48 and a beta of 0.84. The company has a 50 day moving average price of $183.20 and a 200 day moving average price of $156.96. Axon Enterprise, Inc. has a fifty-two week low of $82.49 and a fifty-two week high of $204.99.
Insider Activity at Axon Enterprise
In other Axon Enterprise news, CEO Patrick W. Smith sold 71,499 shares of the business’s stock in a transaction that occurred on Tuesday, January 17th. The shares were sold at an average price of $185.77, for a total transaction of $13,282,369.23. Following the completion of the transaction, the chief executive officer now owns 2,254,734 shares in the company, valued at approximately $418,861,935.18. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other Axon Enterprise news, CEO Patrick W. Smith sold 96,575 shares of the business’s stock in a transaction that occurred on Friday, January 27th. The shares were sold at an average price of $190.49, for a total transaction of $18,396,571.75. Following the completion of the transaction, the chief executive officer now owns 2,748,153 shares in the company, valued at approximately $523,495,664.97. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Patrick W. Smith sold 71,499 shares of the business’s stock in a transaction that occurred on Tuesday, January 17th. The stock was sold at an average price of $185.77, for a total transaction of $13,282,369.23. Following the transaction, the chief executive officer now owns 2,254,734 shares of the company’s stock, valued at approximately $418,861,935.18. The disclosure for this sale can be found here. Over the last quarter, insiders sold 351,128 shares of company stock worth $66,165,548. Corporate insiders own 6.90% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities analysts have commented on the stock. Credit Suisse Group lifted their target price on shares of Axon Enterprise from $152.00 to $200.00 and gave the stock an “outperform” rating in a research note on Tuesday, January 10th. Northland Securities lifted their price target on shares of Axon Enterprise from $140.00 to $160.00 in a research report on Wednesday, November 9th. Needham & Company LLC lifted their price target on shares of Axon Enterprise from $200.00 to $240.00 in a research report on Wednesday, January 25th. Morgan Stanley lifted their price target on shares of Axon Enterprise from $130.00 to $155.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 13th. Finally, JMP Securities lifted their price target on shares of Axon Enterprise from $195.00 to $235.00 and gave the company a “market outperform” rating in a research report on Wednesday, February 1st. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat, Axon Enterprise presently has an average rating of “Moderate Buy” and a consensus price target of $195.00.
Axon Enterprise Profile
Axon Enterprise, Inc engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axon Enterprise, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Axon Enterprise wasn’t on the list.
While Axon Enterprise currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
